SREBF1 and hyperlipidemia: The hyperlipidemia was attributed to elevated FFA and cholesterol synthesis by the liver and adipose tissue caused by activation of SREBP1c and 2, whereas studies in cultured liver cells support the notion that ritonavir might cause a decreased degradation of nascent apoB attributable to inhibition of the 20S proteasome.